SubsidieMeestersFacilitating personalised Lung Treatment Decisions through a Deeptech AI Clinical Decision Support System
Thirona's LungQ-Care project aims to develop an AI-driven clinical decision support system to enhance personalized lung treatment and streamline thoracic imaging analysis.
Projectdetails
Introduction
With the support of EIC funding, Thirona aims to transform their innovative thoracic AI imaging system, LungQ, into an end-to-end clinical decision support system (CDSS) called LungQ-Care.
Current Challenges
The current information workflow of thoracic imaging makes it exceedingly complicated to personalize lung treatments.
Solution Overview
However, LungQ-Care tackles this challenge by enabling radiologists to:
- Quantify medical imaging and disease phenotypes
- Deliver structured analyses to lung doctors
This empowers them to interpret medical imaging effectively and offer personalized treatments to their patients for optimal disease management while reducing costs.
Clinical Impact
LungQ displayed clinical impact by:
- Reducing anaesthesia-induced bronchoscopic interventions by 81.5% for COPD cases.
- Reducing the time to analyze cystic fibrosis images from days to minutes.
Expertise and Future Plans
With medical and technical expertise, Thirona has the capabilities to lay the foundation for a scalable and groundbreaking AI platform in lung care.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.999 |
| Totale projectbegroting | € 4.756.250 |
Tijdlijn
| Startdatum | 1-10-2023 |
| Einddatum | 30-9-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- THIRONA BVpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Development and commercialisation of a novel needle tract sealant system for pneumothorax prevention during lung biopsyThe Selio System aims to prevent pneumothorax during lung biopsies by pre-sealing the needle tract, enhancing patient safety and reducing healthcare costs. | EIC Accelerator | € 2.499.999 | 2022 | Details |
Empowering Radiologists in Cancer Diagnostics with Artificial IntelligenceBetter Medicine AI automates repetitive tasks in cancer CT scan analysis, reducing radiologist workload by 40-60% to improve diagnostic accuracy and address the radiologist shortage. | EIC Accelerator | € 2.499.875 | 2024 | Details |
The first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancerQlucore aims to revolutionize precision oncology by developing AI-driven diagnostic software for cancer, enhancing accuracy in gene analysis and improving survival rates across Europe. | EIC Accelerator | € 2.491.650 | 2024 | Details |
INNOVATIVE LIQUID BIOPSY METHOD USING LAB-ON-ACHIP TECHNOLOGY FOR CANCER DIAGNOSIS AND MANAGEMENTJaxBio aims to revolutionize lung cancer diagnosis and treatment with LUMEN, a non-invasive liquid biopsy assay that detects cancer early and predicts treatment response using advanced DNA-chip technology. | EIC Accelerator | € 2.493.000 | 2024 | Details |
Precision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patientsDoMore Dx offers innovative diagnostics software using deep learning on cancer tissue images to personalize chemotherapy decisions, potentially saving 250,000 patients and 4 billion EUR annually. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Development and commercialisation of a novel needle tract sealant system for pneumothorax prevention during lung biopsy
The Selio System aims to prevent pneumothorax during lung biopsies by pre-sealing the needle tract, enhancing patient safety and reducing healthcare costs.
Empowering Radiologists in Cancer Diagnostics with Artificial Intelligence
Better Medicine AI automates repetitive tasks in cancer CT scan analysis, reducing radiologist workload by 40-60% to improve diagnostic accuracy and address the radiologist shortage.
The first IVDR-approved commercial software solutions for AI-powered RNA-based companion and precision cancer diagnostics of acute myeloid leukaemia and bladder cancer
Qlucore aims to revolutionize precision oncology by developing AI-driven diagnostic software for cancer, enhancing accuracy in gene analysis and improving survival rates across Europe.
INNOVATIVE LIQUID BIOPSY METHOD USING LAB-ON-ACHIP TECHNOLOGY FOR CANCER DIAGNOSIS AND MANAGEMENT
JaxBio aims to revolutionize lung cancer diagnosis and treatment with LUMEN, a non-invasive liquid biopsy assay that detects cancer early and predicts treatment response using advanced DNA-chip technology.
Precision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patients
DoMore Dx offers innovative diagnostics software using deep learning on cancer tissue images to personalize chemotherapy decisions, potentially saving 250,000 patients and 4 billion EUR annually.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Decision support system voor medische diagnosesNobleo ontwikkelt een AI-gestuurd decision support systeem om medische diagnoses te verbeteren en zorgkosten te verlagen. | Mkb-innovati... | € 20.000 | 2020 | Details |
Haalbaarheidsonderzoek nieuwe vroegdiagnose longkanker technologie d.m.v. “remote data services”Het project richt zich op het ontwikkelen van een gestandaardiseerde dienst voor longkankerscreening door hoogwaardige beelddata op afstand te analyseren, om vroegtijdige diagnose en behandeling te verbeteren. | Mkb-innovati... | € 19.992 | 2020 | Details |
Schaalbare AI voor patiënten met pijn op de borstHet project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst. | 1.1 - Het ve... | € 795.688 | 2024 | Details |
Multi-tenant applicatie t.b.v. diagnoses in de acute zorgHet project ontwikkelt een multi-tenant applicatie om artsen in de acute zorg te ondersteunen bij snellere en nauwkeurigere diagnoses. | Mkb-innovati... | € 20.000 | 2024 | Details |
Enhancing emergency department safety, efficacy and cost-effectiveness by artificial intelligenceDevelop a machine learning-based clinical decision support system for emergency medicine to enhance diagnosis accuracy, patient safety, and cost-effectiveness through validated algorithms and patient data integration. | ERC Advanced... | € 2.497.200 | 2022 | Details |
Decision support system voor medische diagnoses
Nobleo ontwikkelt een AI-gestuurd decision support systeem om medische diagnoses te verbeteren en zorgkosten te verlagen.
Haalbaarheidsonderzoek nieuwe vroegdiagnose longkanker technologie d.m.v. “remote data services”
Het project richt zich op het ontwikkelen van een gestandaardiseerde dienst voor longkankerscreening door hoogwaardige beelddata op afstand te analyseren, om vroegtijdige diagnose en behandeling te verbeteren.
Schaalbare AI voor patiënten met pijn op de borst
Het project ontwikkelt een AI-algoritme dat cardiologen ondersteunt bij het aanvragen van CT-scans voor patiënten met pijn op de borst.
Multi-tenant applicatie t.b.v. diagnoses in de acute zorg
Het project ontwikkelt een multi-tenant applicatie om artsen in de acute zorg te ondersteunen bij snellere en nauwkeurigere diagnoses.
Enhancing emergency department safety, efficacy and cost-effectiveness by artificial intelligence
Develop a machine learning-based clinical decision support system for emergency medicine to enhance diagnosis accuracy, patient safety, and cost-effectiveness through validated algorithms and patient data integration.